Risk for relatives of patients with multiple sclerosis in Central Sardinia, Italy

Neuroepidemiology

Volumn 22, Issue 5, 2003, Pages 290-296

  Prokopenko, Inga ^a   Montomoli, Cristina ^a   Ferrai, Raffaela ^b   Musu, Luigina ^b   Piras, Maria Luisa ^b   Ticca, Anna ^b   Murgia, Bruno S ^b   Bernardinelli, Luisa ^a,c  

^a UNIVERSITY OF PAVIA   (Italy)

^b SAN FRANCESCO HOSPITAL   (Italy)

^c MRC BIOSTATISTICS UNIT   (United Kingdom)

Author keywords

Age adjusted risks; Cox proportional hazards model; Multiple sclerosis; Sardinia

Indexed keywords

ADULT; AGE; ANALYTIC METHOD; ARTICLE; CALCULATION; CONFIDENCE INTERVAL; CONSANGUINITY; FEMALE; GENETIC ANALYSIS; HUMAN; ITALY; LIFE TABLE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATIENT; POPULATION STRUCTURE; RECURRENCE RISK; RELATIVE; RISK ASSESSMENT; SIBLING;

CONFIDENCE INTERVALS; CONSANGUINITY; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; MALE; MULTIPLE SCLEROSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK ASSESSMENT; SEX DISTRIBUTION;

EID: 0041660848     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071192     Document Type: Article

References (28)

1. Hohlfeld R: Biotechnological agents for the immunotherapy of multiple sclerosis: Principles, problems and perspectives. Brain 1997;120:865-916.
2. Robertson NP, Clayton D, Fraser M, Deans J, Compston DA: Clinical concordance in sibling pairs with multiple sclerosis. Neurology 1996;47:347-352.
3. Sadovnick AD, Ebers GC, Dyment DA, Risch NJ, and the Canadian Collaborative Study Group: Evidence for genetic basis of multiple sclerosis. Lancet 1996;347:1728-1730.
4. Ebers GC, Yee IM, Sadovnick AD, Duquette P, and the Canadian Collaborative Study Group: Conjugal multiple sclerosis: Population-based prevalence and recurrence risks in offspring. Ann Neurol 2000;48:927-931.
5. Sadovnick AD, Yee IML, Ebers GC, and the Canadian Collaborative Study Group: Recurrence risks to sibs of index cases: Impact of consanguineous matings. Neurology 2001;56:784-785.
6. Wandstrat A, Wakeland E: The genetics of complex autoimmune diseases: Non-MHC susceptibility genes. Nature Immunol 2001;2:802-809.
7. Sadovnick AD, Yee IM, Ebers GC, Risch NJ: Effect of age at onset and parental disease status on sibling risks for MS. Neurology 1998;50:719-723.
8. Piazza A, Mayr WR, Contu L, Amoroso A, Borelli I, Curtoni ES, Marcello C, Moroni A, Olivetti E, Richiardi P, Cappellini R: Genetic and population structure of four Sardinian villages. Ann Hum Genet 1985;49:47-63.
9. Contu L, Arras M, Carcassi C, La Nasa G, Mulargia M: HLA structure of the Sardinian population: A haplotype study of 551 families. Tissue Antigens 1992;40:165-174.
10. Montomoli C, Allemani C, Solinas G, Motta G, Bernardinelli L, Clemente S, Murgia BS, Ticca AF, Musu L, Piras ML, Ferrai R, Caria A, Sanna S, Porcu O: An ecologic study of geographical variation of multiple sclerosis risk in central Sardinia, Italy. Neuroepidemiology 2002;21:187-193.
11. Sotgiu S, Pugliatti M, Sanna A, Sotgiu A, Pastiglia P, Solinas G, Dolei A, Serra C, Sonetti C, Rosati G: Multiple sclerosis complexity in selected populations: The challenge of Sardinia, insular Italy. Eur J Neurol 2002;9:329-341.
12. Bitti PP, Murgia BS, Ticca A, Ferrai R, Musu L, Piras ML, Puledda E, Campo S, Durando S, Montomoli C, Clayton DG, Mander AP, Bernardinelli L: Association between the ancestral haplotype HLA A30B18DR3 and multiple sclerosis in central Sardinia. Genet Epidemiol 2001;20:271-283.
13. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983;13:227-231.
14. Carton H, Vlietinck R, Debruyne J, De Keyser J, D'Hooghe MB, Loos R, Medaer R, Truyen L, Yee IM, Sadovnick AD: Risks of multiple sclerosis in relatives of patients in Flanders, Belgium. J Neurol Neurosurg Psychiatry 1997;62:329-333.
15. Robertson NP, Fraser M, Deans J, Clayton D, Walker N, Compston DA: Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 1996;119:449-455.
16. Sadovnick AD: Familial recurrence risk and inheritance of multiple sclerosis. Curr Opin Neurol Neurosurg 1993;6:189-194.
17. Kleinbaum DG: Survival Analysis: A Self-Learning Text. New York, Springer, 1996.
18. Vogel F, Motulsky AG: Human Genetics. Berlin, Springer, 1997.
19. Montomoli C, Prokopenko I, Caria A, Ferrai R, Mander A, Seaman S, Musu L, Piras ML, Ticca AF, Murgia BS, Bernardinelli L: Multiple sclerosis recurrence risk for siblings in an isolated population of Central Sardinia, Italy. Genetic Epidemiol 2002;22:265-271.
20. Emery AEH: Methodology in Medical Genetics: An Introduction to Statistical Methods, ed 2. New York, Churchill Livingstone, 1986.
21. Cox DR, Oakes D: Analysis of Survival Data. London, Chapman and Hall, 1984.
22. White M: An eteroskedasticity-consistent covariance matrix estimator and a direct test for eteroskedasticity. Econometrika 1980;48:817-830.
23. Sadovnick AD, Baird PA, Ward RH: Multiple sclerosis: Updated risks for relatives. Am J Med Genet 1988;29:533-541.
24. Marrosu MG, Lai M, Cocco E, Loi V, Spinicci G, Pischedda MP, Massole S, Marrosu G, Contu P: Genetic factors and the founder effect explain familial MS in Sardinia. Neurology 2002;58:283-288
25. Bernardinelli L, Pascutto C, Gilks W, Montomoli C, Komakec J, Solinas G, Fiorani O, Lisa A, Zei G, Songini M: Bayesian analysis of ecological data for studying the association between insulin-dependent diabetes mellitus and malaria; in Barnett V, Stein A, Turkman KF (eds): Statistics for the Environment 4: Statistical Aspects of Health and the Environmment. New York, John Wiley & Sons Ltd, 1999, pp 29-48.
26. Cavalli-Sforza L, Bodmer WF: The Genetics of Human Populations. San Francisco, WH Freeman, 1971.
27. Piazza A, Van Loghem E, De Lange G, Curtoni ES, Ulizzi L, Terrenato L: Immunoglobulin allotypes in Sardinia. Am J Hum Genet 1976;28:77-86.
28. Risch N: The genetic epidemiology of cancer: Interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 2001;10:733-741.